Evidence map›Paper›PMID 34341248›Full record

ArticleSaudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association

Development and validation of a nomogram for predicting varices needing treatment in compensated advanced chronic liver disease: A multicenter study.

Jitao Wang, Wenxin Wei, Zhihui Duan, Jinlong Li, Yanna Liu, Chuan Liu, Liting Zhang, Qingge Zhang, Shengyun Zhou, Kunpeng Zhang and 14 more

Open access · diamondAbstract readMulticenter Study
In one paragraph

Article in Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 12 institutions in 1 country.

Jitao WangCHESS Working Party, Xingtai Institute of Cancer Control, Xingtai People's Hospital, Xingtai; CHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, China.
Wenxin WeiDepartment of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.
Zhihui DuanCHESS Working Party, Xingtai Institute of Cancer Control, Xingtai People's Hospital, Xingtai, China.
Jinlong LiCHESS Working Party, Xingtai Institute of Cancer Control, Xingtai People's Hospital, Xingtai, China.
Yanna LiuCHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, China.
Chuan LiuCHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, China.
Liting ZhangCHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, China.
Qingge ZhangCHESS Working Party, Xingtai Institute of Cancer Control, Xingtai People's Hospital, Xingtai, China.
Shengyun ZhouCHESS Working Party, Xingtai Institute of Cancer Control, Xingtai People's Hospital, Xingtai, China.
Kunpeng ZhangCHESS Working Party, Xingtai Institute of Cancer Control, Xingtai People's Hospital, Xingtai, China.
Fengxiao GaoCHESS Working Party, Xingtai Institute of Cancer Control, Xingtai People's Hospital, Xingtai, China.
Xiaojuan WangCHESS Working Party, Xingtai Institute of Cancer Control, Xingtai People's Hospital, Xingtai, China.
Yong LiaoCHESS Working Party, Xingtai Institute of Cancer Control, Xingtai People's Hospital, Xingtai, China.
Dan XuCHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, China.
Yifei HuangCHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, China.
Shuai WangDepartment of Hepatology, The Seventh Medical Center of PLA General Hospital, Beijing, China.
Weiling HuDepartment of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China.
Hua MaoDepartment of Gastroenterology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Ming XuDepartment of Gastroenterology, Guangdong Second Provincial General Hospital, Guangzhou, China.
Tong DangDepartment of Gastroenterology, The Second Affiliated Hospital of Baotou Medical College, Baotou, China.
Bin WuDepartment of Gastroenterology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Li YangDivision of Gastroenterology and Hepatology, Digestive Disease Institute, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai, China.
Dengxiang LiuCHESS Working Party, Xingtai Institute of Cancer Control, Xingtai People's Hospital, Xingtai, China.
Xiaolong QiCHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, China.
Hebei Medical University · CNLanzhou University · CNFirst Hospital of Lanzhou University · CNXingtai People's Hospital · CNBaotou Medical College · CNChinese PLA General Hospital · CNEastern Hepatobiliary Surgery Hospital · CNGuangdong Provincial People's Hospital · CNSir Run Run Shaw Hospital · CNSouthern Medical University · CNThird Affiliated Hospital of Sun Yat-sen University · CNTongji Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOnly a small proportion of patients with compensated advanced chronic liver disease (cACLD) had varices needing treatment (VNT) after recommended esophagogastroduodenoscopy (EGD) screening. We aimed to create a non-invasive nomogram based on routine tests to detect VNT in cACLD patients.

methodsThe training cohort included 162 cACLD patients undergoing EGD in a university hospital, between January 2014 and September 2019. A nomogram was developed based on the independent predictors of VNT, selected using a multivariate logistic regression analysis. Thirty-three patients from eight university hospitals were prospectively enrolled as validation cohort between December 2018 and December 2019.

resultsThe prevalence of VNT was 32.7% (53/162) and 39.4% (13/33) in training and validation cohorts, respectively. The univariate analysis identified six risk factors for VNT. On the multivariate analysis, four of them, i.e., gallbladder wall thickness (odds ratio [OR]: 1.23; 95% confidence interval [CI]: 0.98-1.56), spleen diameter (OR: 1.02; 95% CI: 1.00-1.04), platelet count (OR: 0.98; 95% CI: 0.97-0.99), and international normalized ratio (OR: 0.58; 95% CI: 0.06-5.84) were independently associated with VNT. Thus, a nomogram based on the four above - mentioned variables was developed, and showed a favorable performance for detecting VNT, with an area under receiver operating characteristic curve of 0.848 (95% CI: 0.769-0.927) in training cohort. By applying a cut-off value of 105 in validation cohort, 31.0% of EGD were safely spared with 3.4% of missed VNT.

conclusionA nomogram based on routine clinical parameters was developed for detecting VNT and avoiding unnecessary EGD in cACLD patients.

Indexed as

Esophageal and Gastric VaricesLiver DiseasesVaricose VeinsHumansNomogramsPlatelet CountCompensated advanced chronic liver diseaseesophagogastroduodenoscopynomogramnon-invasivevarices needing treatment

Identifiers

PMID34341248
PMCPMC8656326
OpenAlexW3192040337

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.